Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CERT1 | Q9Y5P4 | 3/20 | 1.00 |
| ▸ | ASAH1 | Q13510 | 2/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.61 |
| ▸ | ACER2 | Q5QJU3 | 1/20 | 0.61 |
| ▸ | SMPD2 | O60906 | 2/20 | 0.52 |
| ▸ | UGCG | Q16739 | 2/20 | 0.51 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | MTOR | P42345 | 1/20 | 0.48 |
| ▸ | GMNN | O75496 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29534221 | 1.00 | CERT1 (1.00) | CERT1ASAH1ALDH1A1ACER2SMPD2 | |
| SCHEMBL31684049 | 0.84 | CERT1 (0.72) | CERT1ASAH1ALDH1A1ACER2SMPD2 | |
| SCHEMBL7765661 | 0.80 | CERT1 (0.67) | CERT1ASAH1ALDH1A1ACER2MEN1 | |
| SCHEMBL7765658 | 0.80 | CERT1 (0.67) | CERT1ASAH1ALDH1A1ACER2MEN1 | |
| SCHEMBL8342096 | 0.80 | CERT1 (0.67) | CERT1ASAH1ALDH1A1ACER2MEN1 | |
| SCHEMBL8383184 | 0.80 | CERT1 (0.67) | CERT1ASAH1ALDH1A1ACER2MEN1 | |
| SCHEMBL7769010 | 0.80 | ASAH1 (0.68) | CERT1ASAH1ALDH1A1ACER2 | |
| SCHEMBL8338663 | 0.80 | ASAH1 (0.68) | CERT1ASAH1ALDH1A1ACER2 | |
| SCHEMBL6570067 | 0.80 | ASAH1 (0.68) | CERT1ASAH1ALDH1A1ACER2 | |
| SCHEMBL7769012 | 0.80 | ASAH1 (0.68) | CERT1ASAH1ALDH1A1ACER2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3970691-A1 | SLIMMING COSMETIC COMPOSITIONS CONTAINING ONE OR MORE LIMONOIDS | C.F.E.B. Sisley (FR) | 2022-03-23 | — | — | EP | disclosed |
| EP-1391198-B1 | NOVEL SPHINGOLIPID SYNTHESIS INHIBITOR | JAPAN SCIENCE & TECH AGENCY (JP) | 2008-01-02 | — | — | EP | disclosed |
| US-6888015-B2 | Sphingolipid synthesis inhibitor | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2005-05-03 | — | — | US | disclosed |
| US-20040092600-A1 | Novel sphingolipid synthesis inhibitor | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2004-05-13 | — | — | US | disclosed |
| EP-1391198-A1 | NOVEL SPHINGOLIPID SYNTHESIS INHIBITOR | Japan Science and Technology Corporation (JP) | 2004-02-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040092600-A1 | Novel sphingolipid synthesis inhibitor | SPTLC1, SPTLC2, SPTLC3 | CERT1 6/4885ASAH1 13/4885ALDH1A1 1567/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.